Peer Review History

Original SubmissionDecember 18, 2023
Decision Letter - Yoshihiro Fukumoto, Editor

PONE-D-23-40936Moxibusiton for declined cardiorespiratory fitness of apparently healthy older adults: a study protocol for a randomized controlled trial

PLOS ONE

Dear Dr. Sun,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

4. We note that Figures 4 and 5 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figures 4 and 5 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a study protocol to evaluate the efficacy of Moxibusiton in elderly. I have a few comments to the authors.

1. Study rationale: What is the rationale to intervene to healthy elderly without hypertension, diabetes, etc? They are asymptomatic and doing well.

2. Inclusion and exclusion criteria should be provided more clearly.

3. Sample size calculation: this trial has 3 arms but sample calculation was done by 2 arms design. Adding additional 35 patients is missing reasonability.

Reviewer #2: This is a design paper for a study examining the improvement of exercise tolerance through moxibustion.

The reviewer has some questions for this study.

1. Aren't people with experience in moxibustion excluded? If subject with experience in moxibustion is assigned to the Sham group, is there a possibility that the subject will realize that the sham procedure is being used?

2. Isn't the effect of moxibustion different depending on the practitioner? Are differences between practitioners taken into consideration?

3. What kind of consideration is given to placing moxibustion at the exact position of the acupuncture points?

4. What are the possible reasons for withdrawal from research? I think there is a possibility that moxibustion cannot be continued due to pain etc.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Responses to the reviewers

Reviewer #1:

This is a study protocol to evaluate the efficacy of Moxibustion in elderly. I have a few comments to the authors.

Our response: We sincerely appreciate your review of our article and the valuable suggestions and comments you provided. Your input plays a pivotal role in enhancing the quality of the paper.

1. Study rationale: What is the rationale to intervene to healthy elderly without hypertension, diabetes, etc? They are asymptomatic and doing well.

Our response: Thank you for this thoughtful question. We selected healthy older adults as research subjects for the following reasons: 1) Even healthy older adults could experience reduced CRF based on our prior observations. In the second paragraph of the “Introduction” section (Line 43-48, Page2-3), we explained that age serves as an independent risk factor for the decline in CRF, not only diseases such as hypertension, diabetes, etc. 2) Healthy older adults with declined CRF may not exhibit obvious symptoms in a relatively quiet state. However, when engaging in essential daily activities such as climbing stairs, walking long distances for shopping, or participating in physical exercise, they may experience limitations, inevitably impacting their quality of life and independence. 3) Consequently, when addressing the issue of reduced CRF, healthy older adults are often overlooked compared to groups with underlying diseases. If moxibustion proves effective in enhancing the CRF of healthy older adults, it would bear significant importance in further enhancing their quality of life.

2. Inclusion and exclusion criteria should be provided more clearly.

Our response: We really appreciate your kind comment. It has come to our attention that our inclusion and exclusion criteria were somewhat unclear, with some content being repetitive.

Following careful deliberation, we have revised and redefined the inclusion and exclusion criteria. We added an inclusion criterion for healthy older adults, and deleted various disease conditions in the exclusion criteria to avoid duplication.

It is important to highlight that we have added an exclusion criterion according to the recommendation of another reviewer: “Participants with previous moxibustion treatment experience”. Given that real moxibustion treatment induces a noticeable warm sensation, unlike sham moxibustion, participants with prior moxibustion experience may discern the difference, potentially compromising the integrity of the study results. For specifics, please refer to Line 107-121, Page 5-6.

3. Sample size calculation: this trial has 3 arms but sample calculation was done by 2 arms design. Adding additional 35 patients is missing reasonability.

Our response: Thank you for bringing attention to this crucial issue. There does appear to be an inconsistency in calculating the sample size using this method. We have re-evaluated it using G-power software version 3.1.9.4. Sample size determination was based on one-way analysis of variance (ANOVA) comparing the VO2peak value of three different groups. A Total sample of 107 participants is required to detect a significant difference with an effect size of 0.35 and 90% power at 5% level of significance (see picture below). Considering an estimated dropout rate of 15%, a total of 126 participants are needed, with 42 for each group. We have revised the “Sample size estimation section” (Line 122-130, Page 6) accordingly. Simultaneously, all other mentions of sample size in the manuscript have been adjusted, including the study flow chart (Fig 2).

----------------------------------

Reviewer #2:

This is a design paper for a study examining the improvement of exercise tolerance through moxibustion.

Our response: Thank you for your careful review of this article. Your questions and comments are of great value to the improvement of our study protocol.

The reviewer has some questions for this study.

1. Aren't people with experience in moxibustion excluded? If subject with experience in moxibustion is assigned to the Sham group, is there a possibility that the subject will realize that the sham procedure is being used?

Our response: We really appreciate this great question! Given that moxibustion treatment induces a noticeable warm sensation, unlike sham moxibustion, subjects with prior moxibustion experience may discern the difference, potentially compromising the integrity of the study results. Therefore, as a precautionary measure, we propose adding an exclusion criterion “With previous moxibustion history or experience” to exclude participants with previous moxibustion experience. The pertinent modification is made in Line 115, Page 6 of the manuscript.

2. Isn't the effect of moxibustion different depending on the practitioner? Are differences between practitioners taken into consideration?

Our response: Thank you for your insightful question. Although moxibustion is less operator-dependent compared to acupuncture, we recognize that variations may arise due to different operators. As far as we know, the factors influencing moxibustion's effectiveness primarily encompass different operators, type of moxibustion, chosen acupoints, moxibustion duration, frequency, and etc. In order to control the influence of these factors on the trial results,

first, we will minimize the number of practitioners and provide training to standardize their techniques, and homogenize the moxibustion operation process as much as possible, thereby mitigating the potential impact. We have an explanation regarding this under the “Data collection, monitoring, and quality control” section, please check Line 326-330, Page 16 for details.

Second, we meticulously control the other influencing factors, ensuring consistency across each group, including the utilization of the same moxa stick manufacturer, same acupoints, unified session duration and frequency, etc.

3. What kind of consideration is given to placing moxibustion at the exact position of the acupuncture points?

Our response: Thanks for your question. We believe this process involves two steps: accurately locating the acupuncture points and precisely positioning the moxibustion device on the acupoints.

For first step, standardized and precise methods for positioning acupoints are available. We will refer to the 2006 National Standard of the People's Republic of China, "Acupoint Names and Locations" (GB/T12346-2006). The acupoint positioning details were elucidated in the “Moxibustion group” section (Line 163-169, Page 8) of the manuscript.

For second step, following accurate acupoints positioning, the practitioners use a marker to mark the acupoint locations on the local skin and subsequently secure the moxibustion equipment on the selected acupoints. Simultaneously, we utilize adhesive tape to firmly affix the moxibustion equipment, preventing any displacement during the moxibustion process.

In response to your query, we have made pertinent adjustments to the description of the moxibustion operation method to make it clearer. Please check Line 173-193, Page 9 for specific details.

4. What are the possible reasons for withdrawal from research? I think there is a possibility that moxibustion cannot be continued due to pain etc.

Our response: We appreciate your insightful question. In clinical studies, it is essential to establish criteria for both dropout and withdrawal. For example, if a participant ceases treatment for personal reasons, it is categorized as dropout. Conversely, if the investigators request the subject's withdrawal from the study due to severe moxibustion-related side effects, it is classified as withdrawal.

We acknowledge that our previous explanations were not sufficiently clear. We only used "Dropout" as the heading, while the content also encompasses instances of withdrawal, such as severe side effects, inadequate treatment compliance, significant alterations in lifestyle habits, and weight changes exceeding 5 kilograms, etc. (Line 224-231, Page 11). Consequently, we have revised the heading to “Dropout and withdrawal", and listed different situations in different categories. Please refer to Line 217-231, Page11 for specific details.

As for the participants you mentioned who withdraw from the study due to pain, we believe it is less likely as our moxibustion protocol is designed to impart a sensation of warmth to the subjects, not pain. Regardless, we appreciate your questions, as they led us to identify an issue in this section and correct the content.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Yoshihiro Fukumoto, Editor

Moxibusiton for declined cardiorespiratory fitness of apparently healthy older adults: a study protocol for a randomized controlled trial

PONE-D-23-40936R1

Dear Dr. Sun,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at http://www.editorialmanager.com/pone/ and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors addresed my comments about rationale, inclusion/exclusion criteria, and sample sizea dequately. I do not have further comments at this point.

Reviewer #2: The revised manuscript has been improved based on my comments. I have no more comments for the revised manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Yoshihiro Fukumoto, Editor

PONE-D-23-40936R1

PLOS ONE

Dear Dr. Zhang,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yoshihiro Fukumoto

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .